Medline, Inc. (MDLN)
39.17
-0.30
(-0.76%)
USD |
NASDAQ |
Nov 16, 16:00
39.10
-0.07
(-0.18%)
After-Hours: 20:00
Medline Debt to Equity Ratio : 1.072 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.072 |
| June 30, 2026 | 1.092 |
| March 31, 2026 | 1.121 |
| December 31, 2025 | 1.212 |
| Date | Value |
|---|---|
| September 30, 2025 | 0.9714 |
| June 30, 2025 | 0.982 |
| March 31, 2025 | |
| December 31, 2024 | 1.023 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.6106 |
| AngioDynamics, Inc. | 0.0655 |
| Alphatec Holdings, Inc. | 27.88 |
| AtriCure, Inc. | 0.1816 |
| Baxter International, Inc. | 1.232 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.18B |
| Total Liabilities (Quarterly) | 20.79B |
| Shareholders Equity (Quarterly) | 11.80B |
| Current Ratio | 4.044 |
| Net Debt Paydown Yield | 2.62% |